BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mathai RA, Vidya RVS, Reddy BS, Thomas L, Udupa K, Kolesar J, Rao M. Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology. J Clin Med 2019;8:E373. [PMID: 30889786 DOI: 10.3390/jcm8030373] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Taylor C, Chacko S, Davey M, Lacroix J, MacPherson A, Finn N, Wajnberg G, Ghosh A, Crapoulet N, Lewis SM, Ouellette RJ. Peptide-Affinity Precipitation of Extracellular Vesicles and Cell-Free DNA Improves Sequencing Performance for the Detection of Pathogenic Mutations in Lung Cancer Patient Plasma. Int J Mol Sci 2020;21:E9083. [PMID: 33260345 DOI: 10.3390/ijms21239083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ender F, Freund A, Quecke T, Steidel C, Zamzow P, von Bubnoff N, Gieseler F. Tissue factor activity on microvesicles from cancer patients. J Cancer Res Clin Oncol 2020;146:467-75. [PMID: 31734835 DOI: 10.1007/s00432-019-03073-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Papadopoulou E, Tsoulos N, Tsantikidi K, Metaxa-Mariatou V, Stamou PE, Kladi-Skandali A, Kapeni E, Tsaousis G, Pentheroudakis G, Petrakis D, Lampropoulou DI, Aravantinos G, Varthalitis I, Kesisis G, Boukovinas I, Papakotoulas P, Katirtzoglou N, Athanasiadis E, Stavridi F, Christodoulou C, Koumarianou A, Eralp Y, Nasioulas G. Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients. PLoS One 2019;14:e0226853. [PMID: 31860648 DOI: 10.1371/journal.pone.0226853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
4 Zhuang W, Camacho L, Silva CS, Hong H. Reproducibility challenges for biomarker detection with uncertain but informative experimental data. Biomark Med 2020;14:1255-63. [PMID: 33021389 DOI: 10.2217/bmm-2019-0599] [Reference Citation Analysis]
5 Bocanegra A, Blanco E, Fernandez-Hinojal G, Arasanz H, Chocarro L, Zuazo M, Morente P, Vera R, Escors D, Kochan G. PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy. Int J Mol Sci 2020;21:E5918. [PMID: 32824655 DOI: 10.3390/ijms21165918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen H, Luo D, Shang B, Cao J, Wei J, Chen Q, Chen J. Immunoassay-type biosensor based on magnetic nanoparticle capture and the fluorescence signal formed by horseradish peroxidase catalysis for tumor-related exosome determination. Microchim Acta 2020;187. [DOI: 10.1007/s00604-020-04275-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
7 Laurenzana I, Trino S, Lamorte D, Girasole M, Dinarelli S, De Stradis A, Grieco V, Maietti M, Traficante A, Statuto T, Villani O, Musto P, Sgambato A, De Luca L, Caivano A. Analysis of Amount, Size, Protein Phenotype and Molecular Content of Circulating Extracellular Vesicles Identifies New Biomarkers in Multiple Myeloma. Int J Nanomedicine 2021;16:3141-60. [PMID: 33994784 DOI: 10.2147/IJN.S303391] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang L, Luo H, Wang L, Liu Y, Rui S, Wu Z, Wei T, Gong R, Li Z, Zhu J. Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer. J Surg Oncol 2020;122:897-905. [PMID: 32596828 DOI: 10.1002/jso.26089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Opławski M, Nowakowski R, Średnicka A, Ochnik D, Grabarek BO, Boroń D. Molecular Landscape of the Epithelial-Mesenchymal Transition in Endometrioid Endometrial Cancer. J Clin Med 2021;10:1520. [PMID: 33917330 DOI: 10.3390/jcm10071520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang X, Li B. Updates of liquid biopsy in oral cancer and multiomics analysis. Oral Dis 2021. [PMID: 34716963 DOI: 10.1111/odi.14064] [Reference Citation Analysis]
11 Wang S, Zhang K, Tan S, Xin J, Yuan Q, Xu H, Xu X, Liang Q, Christiani DC, Wang M, Liu L, Du M. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Mol Cancer 2021;20:13. [PMID: 33430880 DOI: 10.1186/s12943-020-01298-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
12 Belli R, Ferraro E, Molfino A, Carletti R, Tambaro F, Costelli P, Muscaritoli M. Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs. Int J Mol Sci 2021;22:9007. [PMID: 34445710 DOI: 10.3390/ijms22169007] [Reference Citation Analysis]
13 Rao M, Venkatraman P, Mukhopadhyay D, Roychoudhury S, Vanderford NL, Rangnekar VM. Value added by an inter-continental cancer consortium. Genes Cancer 2021;12:65-8. [PMID: 34046148 DOI: 10.18632/genesandcancer.215] [Reference Citation Analysis]
14 Luo YH, Liu H, Wampfler JA, Tazelaar HD, Li Y, Peikert T, Liu D, Leventakos K, Chen YM, Yang Y, Chiou SH, Yang P. Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation. J Cancer Res Clin Oncol 2021. [PMID: 34436667 DOI: 10.1007/s00432-021-03766-5] [Reference Citation Analysis]
15 Yang H, Liu Z, Wang Y, Li J, Li R, Wang Q, Hu C, Jiang H, Wu H, Song L, Bai Y. Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC. Ther Adv Med Oncol 2020;12:1758835920970845. [PMID: 33240400 DOI: 10.1177/1758835920970845] [Reference Citation Analysis]
16 Ansari S, de Wildt BWM, Vis MAM, de Korte CE, Ito K, Hofmann S, Yuana Y. Matrix Vesicles: Role in Bone Mineralization and Potential Use as Therapeutics. Pharmaceuticals (Basel) 2021;14:289. [PMID: 33805145 DOI: 10.3390/ph14040289] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Li Q, Peng K, Chen E, Jiang H, Wang Y, Yu S, Li W, Yu Y, Liu T. IntegrinB5 upregulated by HER2 in gastric cancer: a promising biomarker for liver metastasis. Ann Transl Med 2020;8:451. [PMID: 32395495 DOI: 10.21037/atm.2020.03.184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Alizadeh-sedigh M, Mahmoodzadeh H, Fazeli MS, Haddadi-aghdam M, Teimoori-toolabi L. The potential of PIK3CA, KRAS, BRAF, and APC hotspot mutations as a non-invasive detection method for colorectal cancer. Molecular and Cellular Probes 2022. [DOI: 10.1016/j.mcp.2022.101807] [Reference Citation Analysis]
19 Wu J, Hu S, Zhang L, Xin J, Sun C, Wang L, Ding K, Wang B. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis. Theranostics 2020;10:4544-56. [PMID: 32292514 DOI: 10.7150/thno.40532] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
20 Jain M, Kamalov D, Tivtikyan A, Balatsky A, Samokhodskaya L, Okhobotov D, Kozlova P, Pisarev E, Zvereva M, Kamalov A. Urine TERT promoter mutations-based tumor DNA detection in patients with bladder cancer: A pilot study. Mol Clin Oncol 2021;15:253. [PMID: 34712485 DOI: 10.3892/mco.2021.2415] [Reference Citation Analysis]
21 Pinzani P, D'Argenio V, Del Re M, Pellegrini C, Cucchiara F, Salvianti F, Galbiati S. Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors. Clin Chem Lab Med 2021;59:1181-200. [PMID: 33544478 DOI: 10.1515/cclm-2020-1685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Romano A, Palumbo GA, Parrinello NL, Conticello C, Martello M, Terragna C. Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives. Front Oncol 2019;9:699. [PMID: 31482061 DOI: 10.3389/fonc.2019.00699] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
23 Tatischeff I. Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles. Int J Mol Sci 2021;22:5674. [PMID: 34073560 DOI: 10.3390/ijms22115674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Costa C, Muinelo-Romay L, Cebey-López V, Pereira-Veiga T, Martínez-Pena I, Abreu M, Abalo A, Lago-Lestón RM, Abuín C, Palacios P, Cueva J, Piñeiro R, López-López R. Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes. Cancers (Basel) 2020;12:E1111. [PMID: 32365530 DOI: 10.3390/cancers12051111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
25 Vafaei S, Fattahi F, Ebrahimi M, Janani L, Shariftabrizi A, Madjd Z. Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review. Cancer Manag Res 2019;11:8669-98. [PMID: 31576171 DOI: 10.2147/CMAR.S219699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
26 Lu J, Pang J, Chen Y, Dong Q, Sheng J, Luo Y, Lu Y, Lin B, Liu T. Application of Microfluidic Chips in Separation and Analysis of Extracellular Vesicles in Liquid Biopsy for Cancer. Micromachines (Basel) 2019;10:E390. [PMID: 31212643 DOI: 10.3390/mi10060390] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Herrero C, de la Fuente A, Casas-Arozamena C, Sebastian V, Prieto M, Arruebo M, Abalo A, Colás E, Moreno-Bueno G, Gil-Moreno A, Vilar A, Cueva J, Abal M, Muinelo-Romay L. Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer. Cancers (Basel) 2019;11:E2000. [PMID: 31842290 DOI: 10.3390/cancers11122000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
28 Lei CS, Kung HJ, Shih JW. Long Non-Coding RNAs as Functional Codes for Oral Cancer: Translational Potential, Progress and Promises. Int J Mol Sci 2021;22:4903. [PMID: 34063159 DOI: 10.3390/ijms22094903] [Reference Citation Analysis]
29 Baburaj G, Damerla RR, Udupa KS, Parida P, Munisamy M, Kolesar J, Rao M. Liquid biopsy approaches for pleural effusion in lung cancer patients. Mol Biol Rep 2020;47:8179-87. [PMID: 33029702 DOI: 10.1007/s11033-020-05869-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Glogovitis I, Yahubyan G, Würdinger T, Koppers-Lalic D, Baev V. miRGalaxy: Galaxy-Based Framework for Interactive Analysis of microRNA and isomiR Sequencing Data. Cancers (Basel) 2021;13:5663. [PMID: 34830818 DOI: 10.3390/cancers13225663] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Holm M, Andersson E, Osterlund E, Ovissi A, Soveri LM, Anttonen AK, Kytölä S, Aittomäki K, Osterlund P, Ristimäki A. Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing. PLoS One 2020;15:e0239819. [PMID: 33237900 DOI: 10.1371/journal.pone.0239819] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
32 Rodríguez J, Avila J, Rolfo C, Ruíz-Patiño A, Russo A, Ricaurte L, Ordóñez-Reyes C, Arrieta O, Zatarain-Barrón ZL, Recondo G, Cardona AF. When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review. Oncol Ther 2021;9:89-110. [PMID: 33689160 DOI: 10.1007/s40487-021-00144-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Luo D, Li C, Wu L, Chen Q. [Advances of Exosomes Extraction and Its Mechanism in Early Diagnosis of Lung Cancer]. Zhongguo Fei Ai Za Zhi 2020;23:999-1006. [PMID: 32752584 DOI: 10.3779/j.issn.1009-3419.2020.101.24] [Reference Citation Analysis]
34 Dalal S, Petersen J, Jhala D. Liquid Biopsies in a Veteran Patient Population With Advanced Prostate and Lung Non-Small Cell Carcinomas: A New Paradigm and Unique Challenge in Personalized Medicine. Fed Pract 2021;38:8-14. [PMID: 33574643 DOI: 10.12788/fp.0065] [Reference Citation Analysis]
35 Urabe F, Kosaka N, Ito K, Kimura T, Egawa S, Ochiya T. Extracellular vesicles as biomarkers and therapeutic targets for cancer. Am J Physiol Cell Physiol 2020;318:C29-39. [PMID: 31693397 DOI: 10.1152/ajpcell.00280.2019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
36 Chen X, Wang H, Huang Y, Chen Y, Chen C, Zhuo W, Teng L. Comprehensive Roles and Future Perspectives of Exosomes in Peritoneal Metastasis of Gastric Cancer. Front Oncol 2021;11:684871. [PMID: 34268118 DOI: 10.3389/fonc.2021.684871] [Reference Citation Analysis]
37 Pessoa LS, Heringer M, Ferrer VP. ctDNA as a cancer biomarker: A broad overview. Crit Rev Oncol Hematol. 2020;155:103109. [PMID: 33049662 DOI: 10.1016/j.critrevonc.2020.103109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
38 Pandita P, Wang X, Jones DE, Collins K, Hawkins SM. Unique Molecular Features in High-Risk Histology Endometrial Cancers. Cancers (Basel) 2019;11:E1665. [PMID: 31717878 DOI: 10.3390/cancers11111665] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Fina E, Federico D, Novellis P, Dieci E, Monterisi S, Cioffi F, Mangiameli G, Finocchiaro G, Alloisio M, Veronesi G. Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:4488. [PMID: 34503298 DOI: 10.3390/cancers13174488] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Yee NS. Liquid Biopsy: A Biomarker-Driven Tool towards Precision Oncology. J Clin Med 2020;9:E2556. [PMID: 32784545 DOI: 10.3390/jcm9082556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Nicolazzo C, Barault L, Caponnetto S, Macagno M, De Renzi G, Gradilone A, Belardinilli F, Cortesi E, Di Nicolantonio F, Gazzaniga P. Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients. Cancers (Basel) 2020;12:E3633. [PMID: 33291569 DOI: 10.3390/cancers12123633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Zhang J, Shi J, Zhang H, Zhu Y, Liu W, Zhang K, Zhang Z. Localized fluorescent imaging of multiple proteins on individual extracellular vesicles using rolling circle amplification for cancer diagnosis. J Extracell Vesicles 2020;10:e12025. [PMID: 33304477 DOI: 10.1002/jev2.12025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
43 Guzman NA, Guzman DE. A Two-Dimensional Affinity Capture and Separation Mini-Platform for the Isolation, Enrichment, and Quantification of Biomarkers and Its Potential Use for Liquid Biopsy. Biomedicines 2020;8:E255. [PMID: 32751506 DOI: 10.3390/biomedicines8080255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
44 Niwinska A, Bałabas A, Kulecka M, Kluska A, Piątkowska M, Paziewska A, Pyśniak K, Olszewski W, Mikula M, Ostrowski J. Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer. Diagnostics (Basel) 2020;10:E523. [PMID: 32731384 DOI: 10.3390/diagnostics10080523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Gao J, Li S, Xu Q, Zhang X, Huang M, Dai X, Liu L. Exosomes Promote Pre-Metastatic Niche Formation in Gastric Cancer. Front Oncol 2021;11:652378. [PMID: 34109113 DOI: 10.3389/fonc.2021.652378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Koçana CÇ, Toprak SF, Sözer S. Extracellular genetic materials and their application in clinical practice. Cancer Genet 2021;252-253:48-63. [PMID: 33387935 DOI: 10.1016/j.cancergen.2020.12.006] [Reference Citation Analysis]
47 Cullinane C, Fleming C, O'Leary DP, Hassan F, Kelly L, O'Sullivan MJ, Corrigan MA, Redmond HP. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open 2020;3:e2026921. [PMID: 33211112 DOI: 10.1001/jamanetworkopen.2020.26921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Urabe F, Kimura T, Ito K, Yamamoto Y, Tsuzuki S, Miki J, Ochiya T, Egawa S. Urinary extracellular vesicles: a rising star in bladder cancer management. Transl Androl Urol 2021;10:1878-89. [PMID: 33968676 DOI: 10.21037/tau-20-1039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Singh PK, Kumar R, Bal A, Gupta N, Kapoor R, Prasad KT, Singh N. Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease. JCO Glob Oncol 2020;6:174-9. [PMID: 32031456 DOI: 10.1200/JGO.19.00357] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Kerachian MA, Poudineh A, Thiery JP. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine. Critical Reviews in Oncology/Hematology 2019;144:102827. [DOI: 10.1016/j.critrevonc.2019.102827] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
51 Tieng FYF, Abu N, Lee LH, Ab Mutalib NS. Microsatellite Instability in Colorectal Cancer Liquid Biopsy-Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker. Diagnostics (Basel) 2021;11:544. [PMID: 33803882 DOI: 10.3390/diagnostics11030544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Franceschini T, Giunchi F, Montironi R, Scarpelli M, Lopez-Beltran A, Cheng L, Fiorentino M. Liquid biopsies in urological cancers: what we need to know before starting using them. Expert Rev Mol Diagn 2020;20:135-9. [PMID: 31509027 DOI: 10.1080/14737159.2019.1665508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Vacante M, Ciuni R, Basile F, Biondi A. The Liquid Biopsy in the Management of Colorectal Cancer: An Overview. Biomedicines. 2020;8. [PMID: 32858879 DOI: 10.3390/biomedicines8090308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]